I'm actually not too uncomfortable with this cr. Annoying as it is. Early on bio companies need lots of cash. Things happen along the way that can be unforeseen. I wouldn't like to see the bank account down too low early next year either. You have to maintain cash for opex.As for partners. I don't want to see a pharma come in now and take say 40% of the company at a bargain price and pay for the trials. A partner comes in at the end when the trial is successful and the drug needs bringing to the market. That's when you need gazillions.Imho & dyor
I'm actually not too uncomfortable with this cr. Annoying as it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
-0.001(2.00%) |
Mkt cap ! $77.84M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.5¢ | 2.4¢ | $26.17K | 1.089M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 3662851 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 1070977 | 5 |
View Market Depth
| Last trade - 10.55am 31/07/2025 (20 minute delay) ? |
| ACW (ASX) Chart |